17-10-6　ⓔ文献

  1. Bennett JM, Catovsky D, et al: Proposals for the classification of the acute leukaemias. French–American–British (FAB) co–operative group. Br J Haematol, 1976; 33: 451–458.

  2. Arber DA, Orazi A, et al: The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood, 2016; 127:2391–2405.

  3. Welch JS, Ley TJ, et al: The origin and evolution of mutation in acute myeloid leukemia. Cell, 2012; 150: 264–278.

  4. The Cancer Genome Atlas Research Network, Ley TJ, et al: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med, 2013; 368: 2059–2074.

  5. Ding L, Ley TJ, et al: Clonal evolution in relapsed acute myeloid leukaemia revealed by whole–genome sequencing. Nature, 2012; 481: 506–510.

  6. Walter MJ, Shen D, et al: Clonal architecture of secondary acute myeloid leukemia. N Engl J Med, 2012; 366: 1090–1098.

  7. Gondek LP, DeZern AE: Assesing clonal haematopoiesis: clinical burdens and benefits of diagnosing myelodysplastic syndrome precursor states. Lancet Haematol, 2020; 7: e73–e81.

  8. Asakura H: Classifying types of disseminated intravascular coagulation: clinical and animal models. Intensive Care, 2014; 506: 328–333.

  9. Freifeld AG, Bow EJ, et al: Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis, 2011; 52: e56–e93.

  10. Döhner H, Estey E, et al: Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel. Blood, 2017; 129: 424–447.

  11. NCCN Clinical Practice Guidelines in Oncology: Acute Myeloid Leukemia version 1.2020. https://www.nccn.org/professionals/physician_gls/default.aspx

  12. Pollyea DA, Cohort HE, et al: Acute myeloid leukemia in the elderly: a review. Br J Haematol, 2011; 29: 487–494.

  13. 日本血液学会編：造血器腫瘍診療ガイドライン2018年版．補訂版

http://www.jshem.or.jp/gui-hemali/1_1.html

  1. 日本造血細胞移植学会編：造血細胞移植ガイドライン 急性骨髄性白血病 (成人) 第3版，2019．https://www.jshct.com/uploads/files/guideline/03_01_aml03.pdf

  2. Kassim AA, Savani BN: Hematopoietic stem cell transplantation for acute myeloid leukemia: a review. Hematol Oncol Stem Cell Ther, 2017: 245–251.

  3. Platzbecker U, Avvisati G, et al: Improved outcomes with retinoic acid and arsenic trioxide compared with retinoic acid and chemotherapy in non–high–risk acute promyelocytic leukemia: final results of the randomized Italian–German APL0406 Trial. J Clin Oncol. 2017; 35: 605–612.

  4. Jongen-Lavrencic M, Grob T, et al: Molecular minimal residual disease in acute myeloid leukemia. N Engl J Med, 2018; 378: 1189–1199.